Our consolidated statements of income include sales to and purchases from unconsolidated affiliates in the ordinary course of business as follows (in thousands):


	Year Ended December 31,
	2022		2021		2020
Sales to unconsolidated affiliates	$	51,906	$	19,441	$	22,589
Purchases from unconsolidated affiliates(a)	$	1,920,476	$	213,077	$	168,072

(a)Increases in purchases from unconsolidated affiliates primarily relate to increased pricing and volume of spodumene purchased from the Company’s Windfield joint venture.

Our consolidated balance sheets include accounts receivable due from and payable to unconsolidated affiliates in the ordinary course of business as follows (in thousands):


	December 31,
	2022		2021
Receivables from related parties	$	21,495	$	2,139
Payables to related parties(a)	$	518,377	$	47,499

(a)Increases in payables to unconsolidated affiliates primarily relate to increased purchases of spodumene purchased from the Company’s joint venture under normal payment terms.